Table 1.
Features used in histological assessment. Definitions and percent response of all pathologists for each item in cases of Biliary Atresia (BA) and non-BA
ITEM | DEFINITION | % RESPONSES | |
---|---|---|---|
BA CASES | NON-BA CASES | ||
Visible bile plugs | absent | 9 | 30 |
canalicular only | 22 | 47 | |
bile duct only | 6 | 1 | |
bile duct and canalicular | 63 | 22 | |
Hepatocellular swelling1 | absent/rare | 30 | 23 |
<50% of hepatocytes | 47 | 32 | |
>50% of hepatocytes | 23 | 45 | |
Steatosis2 | absent/rare | 80 | 88 |
<50% of hepatocytes | 19 | 10 | |
>50% of hepatocytes | 1 | 2 | |
Pseudorosette formation | absent/rare | 47 | 55 |
present | 45 | 37 | |
prominent | 8 | 7 | |
Hepatocellular multinucleation3 | absent/rare | 49 | 41 |
present | 37 | 36 | |
prominent | 14 | 23 | |
Hepatocellular necrosis | absent/rare | 65 | 63 |
few hepatocytes | 31 | 32 | |
many hepatocytes | 4 | 5 | |
Extramedullary hematopoiesis | absent/rare | 48 | 40 |
present | 47 | 36 | |
extensive | 5 | 23 | |
Lobular fibrosis4 | absent | 80 | 68 |
present | 17 | 23 | |
prominent | 3 | 8 | |
Portal tract edema | absent | 55 | 90 |
present | 45 | 10 | |
Grading of portal fibrosis | absent or fibrous expansion of some portal areas | 8 | 60 |
fibrous expansion of most portal areas | 22 | 26 | |
focal portal-to-portal bridging | 34 | 11 | |
marked bridging | 24 | 3 | |
cirrhosis | 12 | 0 | |
Portal cellular infiltrate5 | absent/minimal | 13 | 40 |
mild | 59 | 40 | |
moderate/marked | 28 | 20 | |
Acute cholangitis6 | absent | 63 | 86 |
present in occasional ducts | 34 | 13.5 | |
marked | 3 | 0.5 | |
Periductular neutrophils | absent | 31 | 57 |
mild –present around occasional ducts | 57 | 38 | |
marked | 12 | 5 | |
Mononuclear inflammatory cells in ducts7 | absent | 69 | 81.5 |
mild- present in occasional ducts | 30 | 18 | |
multiple | 1 | 0.5 | |
Ductal plate malformation | absent | 86 | 99.5 |
present | 14 | 0.5 | |
Bile ductular proliferation | none | 4 | 54 |
focal | 19 | 24 | |
generalized | 76 | 22 |
Hepatocellular swelling: Swelling is enlargement of the cell with rarefaction of the cytoplasm, in the absence of distinct vacuoles
Steatosis: Refers to micro- and macro-vesicular steatosis
Hepatocellular multinucleation (Giant cell transformation): Giant cell transformation means multinucleated (3 or more nuclei) hepatocytes independent of cell size. Cell swelling is scored separately.
Lobular fibrosis: Evaluated using trichrome stain, assessing only zone 3
Portal cellular infiltrate: Includes extramedullary hematopoiesis
Acute cholangitis: Presence of neutrophils in duct or ductules, or infiltrating biliary epithelium. Ducts or ductules defined as a lumen with a cuboidal epithelium.
Mononuclear inflammatory cells in ducts: Also if infiltrating biliary epithelium